Benkowitz Michael's Form 4 filing
United Therapeutics Corp (UTHR) · filed Nov 4, 2025
- Accession no.
- 0001673232-25-000010
- Filed
- Nov 4, 2025
- Trade date
- Nov 3, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 13 non-derivative transactions and 2 derivative transactions. Open-market sales total $9.66M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benkowitz MichaelCIK 0001673232 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2025 | Common Stock | MOption exerciseAcquired | +14,625 | $135.42 | +$1,980,517.5 | 14,625 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −964 | $432.55 | −$416,978.2 | 13,661 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −2,687 | $433.52 | −$1,164,868.24 | 10,974 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −2,918 | $434.68 | −$1,268,396.24 | 8,056 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −3,204 | $435.52 | −$1,395,406.08 | 4,852 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −2,121 | $436.45 | −$925,710.45 | 2,731 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −890 | $437.70 | −$389,553 | 1,841 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −585 | $438.34 | −$256,428.9 | 1,256 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −575 | $439.35 | −$252,626.25 | 681 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −511 | $440.71 | −$225,202.81 | 170 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −170 | $441.94 | −$75,129.8 | 0 | Indirect | |
| Nov 3, 2025 | Common Stock | MOption exerciseAcquired | +7,875 | $146.03 | +$1,149,986.25 | 7,875 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −7,875 | $417.50 | −$3,287,812.5 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2025 | Common Stock | MOption exerciseDisposed | −14,625 | $0.00 | $0 | 41,250 | Indirect | |
| Nov 3, 2025 | Common Stock | MOption exerciseDisposed | −10,500 | $0.00 | $0 | 10,500 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.